Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) shares traded down 3.5% on Friday . The company traded as low as $2.50 and last traded at $2.61. 1,068 shares changed hands during trading, a decline of 56% from the average session volume of 2,414 shares. The stock had previously closed at $2.70.
Relief Therapeutics Stock Down 3.5 %
The company has a fifty day moving average of $2.84 and a 200-day moving average of $4.14.
Relief Therapeutics Company Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Featured Articles
- Five stocks we like better than Relief Therapeutics
- How to Buy Gold Stock and Invest in Gold
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Top Analyst-Rated Healthcare Stocks to Watch Now
- How to Buy Cheap Stocks Step by Step
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
